Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinibEthan Poteet(Baylor College of Medicine), Qizhi Yao(Baylor College of Medicine)PLoS ONEMarch 28, 201910.1371/journal.pone.0213294Cited by 10SaveCiteExport RISWatch citationsRelated PapersMesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression|Molecular Cancer|2011|146Mesothelin-Associated Anti-Senescence Through P53 in Pancreatic Ductal Adenocarcinoma|Cancers|2025|0